ONCOSIL MEDICAL LIMITED ABN 89 113 824 141 ASX | OSL Level 5, 7 Eden Park Drive, Macquarie Park, NSW 2113 AUSTRALIA TELEPHONE +61 2 8935 9629 WEB www.oncosil.com 1 ASX Announcement 8 September 2026 100th Patient Treated with OncoSil™ device in Spain Key highlights • The 100th patient has...
100th Patient Treated with OncoSil device in Spain
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from OncoSil Medical
- OSL Secures $5.6 million from Major Institutional Investors
- Proposed issue of securities - OSL
- OncoSil submits US Reimbursement Application (Updated)
- OncoSil submits US Reimbursement Application
- Appendix 4G and Corporate Governance Statement
Later from OncoSil Medical
- Australian Manufacturing Facility Achieves ISO 13485
- Application for quotation of securities - OSL
- Notice Under Section 708A
- Change in substantial shareholding for OSL
- Change in substantial holding
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical